Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Condition:   Asthma Interventions:   Drug: CSJ117;   Drug: Placebo Sponsor:   Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - June 1, 2020 Category: Research Source Type: clinical trials